Maternal betamethasone administration reduces binucleate cell number and placental lactogen in sheep

Thorsten Braun, Shaofu Li, Timothy Moss, John Newnham, John Challis, Peter Gluckman, Deborah M Sloboda

Research output: Contribution to journalArticleResearchpeer-review

Abstract

The placenta may mediate glucocorticoid-induced fetal growth restriction. Previous studies have examined effects of fetal cortisol in sheep, which reduces placental binucleate cell (BNC) number; the source of ovine placental lactogen (oPL). The effects of maternal GC are unknown. Therefore, this study examined the effects of maternal betamethasone (BET) administration on BNC number, distribution, placental oPL protein levels, and maternal and fetal plasma oPL levels. Pregnant ewes were randomized to receive injections of saline or one (104 days of gestation; dG), two (104 and 111 dG), or three (104, 111, and 118 dG) doses of BET (0.5 mg/kg). Placental tissue was collected before, during, and after the period of BET treatment. Fetal (121-146 dG) and placental (121 dG) weights were decreased after BET when compared with controls. In controls, the mean number of BNCs increased until 132 dG and decreased thereafter. Placental oPL protein levels peaked at 109 dG and remained stable thereafter. Maternal plasma oPL levels in controls increased across gestation; fetal plasma oPL levels decreased. BNCs were reduced by 24 to 47 after BET when compared with controls at all ages studied. Placental oPL protein levels, maternal, and fetal plasma oPL levels were also reduced after BET injections, but recovered to values that were not different to controls near term. BET disrupted the normal distribution of BNCs within the placentome. These data may suggest a placental role in growth restrictive effects of prenatal maternal BET exposure through alterations in placental output of oPL, a key metabolic hormone of pregnancy.
Original languageEnglish
Pages (from-to)337 - 347
Number of pages11
JournalJournal of Endocrinology
Volume194
Issue number2
DOIs
Publication statusPublished - 2007
Externally publishedYes

Cite this

Braun, Thorsten ; Li, Shaofu ; Moss, Timothy ; Newnham, John ; Challis, John ; Gluckman, Peter ; Sloboda, Deborah M. / Maternal betamethasone administration reduces binucleate cell number and placental lactogen in sheep. In: Journal of Endocrinology. 2007 ; Vol. 194, No. 2. pp. 337 - 347.
@article{ee139bf529b943bdb34e48981ad45100,
title = "Maternal betamethasone administration reduces binucleate cell number and placental lactogen in sheep",
abstract = "The placenta may mediate glucocorticoid-induced fetal growth restriction. Previous studies have examined effects of fetal cortisol in sheep, which reduces placental binucleate cell (BNC) number; the source of ovine placental lactogen (oPL). The effects of maternal GC are unknown. Therefore, this study examined the effects of maternal betamethasone (BET) administration on BNC number, distribution, placental oPL protein levels, and maternal and fetal plasma oPL levels. Pregnant ewes were randomized to receive injections of saline or one (104 days of gestation; dG), two (104 and 111 dG), or three (104, 111, and 118 dG) doses of BET (0.5 mg/kg). Placental tissue was collected before, during, and after the period of BET treatment. Fetal (121-146 dG) and placental (121 dG) weights were decreased after BET when compared with controls. In controls, the mean number of BNCs increased until 132 dG and decreased thereafter. Placental oPL protein levels peaked at 109 dG and remained stable thereafter. Maternal plasma oPL levels in controls increased across gestation; fetal plasma oPL levels decreased. BNCs were reduced by 24 to 47 after BET when compared with controls at all ages studied. Placental oPL protein levels, maternal, and fetal plasma oPL levels were also reduced after BET injections, but recovered to values that were not different to controls near term. BET disrupted the normal distribution of BNCs within the placentome. These data may suggest a placental role in growth restrictive effects of prenatal maternal BET exposure through alterations in placental output of oPL, a key metabolic hormone of pregnancy.",
author = "Thorsten Braun and Shaofu Li and Timothy Moss and John Newnham and John Challis and Peter Gluckman and Sloboda, {Deborah M}",
year = "2007",
doi = "10.1677/JOE-07-0123",
language = "English",
volume = "194",
pages = "337 -- 347",
journal = "Journal of Endocrinology",
issn = "0022-0795",
publisher = "Bioscientifica",
number = "2",

}

Maternal betamethasone administration reduces binucleate cell number and placental lactogen in sheep. / Braun, Thorsten; Li, Shaofu; Moss, Timothy; Newnham, John; Challis, John; Gluckman, Peter; Sloboda, Deborah M.

In: Journal of Endocrinology, Vol. 194, No. 2, 2007, p. 337 - 347.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Maternal betamethasone administration reduces binucleate cell number and placental lactogen in sheep

AU - Braun, Thorsten

AU - Li, Shaofu

AU - Moss, Timothy

AU - Newnham, John

AU - Challis, John

AU - Gluckman, Peter

AU - Sloboda, Deborah M

PY - 2007

Y1 - 2007

N2 - The placenta may mediate glucocorticoid-induced fetal growth restriction. Previous studies have examined effects of fetal cortisol in sheep, which reduces placental binucleate cell (BNC) number; the source of ovine placental lactogen (oPL). The effects of maternal GC are unknown. Therefore, this study examined the effects of maternal betamethasone (BET) administration on BNC number, distribution, placental oPL protein levels, and maternal and fetal plasma oPL levels. Pregnant ewes were randomized to receive injections of saline or one (104 days of gestation; dG), two (104 and 111 dG), or three (104, 111, and 118 dG) doses of BET (0.5 mg/kg). Placental tissue was collected before, during, and after the period of BET treatment. Fetal (121-146 dG) and placental (121 dG) weights were decreased after BET when compared with controls. In controls, the mean number of BNCs increased until 132 dG and decreased thereafter. Placental oPL protein levels peaked at 109 dG and remained stable thereafter. Maternal plasma oPL levels in controls increased across gestation; fetal plasma oPL levels decreased. BNCs were reduced by 24 to 47 after BET when compared with controls at all ages studied. Placental oPL protein levels, maternal, and fetal plasma oPL levels were also reduced after BET injections, but recovered to values that were not different to controls near term. BET disrupted the normal distribution of BNCs within the placentome. These data may suggest a placental role in growth restrictive effects of prenatal maternal BET exposure through alterations in placental output of oPL, a key metabolic hormone of pregnancy.

AB - The placenta may mediate glucocorticoid-induced fetal growth restriction. Previous studies have examined effects of fetal cortisol in sheep, which reduces placental binucleate cell (BNC) number; the source of ovine placental lactogen (oPL). The effects of maternal GC are unknown. Therefore, this study examined the effects of maternal betamethasone (BET) administration on BNC number, distribution, placental oPL protein levels, and maternal and fetal plasma oPL levels. Pregnant ewes were randomized to receive injections of saline or one (104 days of gestation; dG), two (104 and 111 dG), or three (104, 111, and 118 dG) doses of BET (0.5 mg/kg). Placental tissue was collected before, during, and after the period of BET treatment. Fetal (121-146 dG) and placental (121 dG) weights were decreased after BET when compared with controls. In controls, the mean number of BNCs increased until 132 dG and decreased thereafter. Placental oPL protein levels peaked at 109 dG and remained stable thereafter. Maternal plasma oPL levels in controls increased across gestation; fetal plasma oPL levels decreased. BNCs were reduced by 24 to 47 after BET when compared with controls at all ages studied. Placental oPL protein levels, maternal, and fetal plasma oPL levels were also reduced after BET injections, but recovered to values that were not different to controls near term. BET disrupted the normal distribution of BNCs within the placentome. These data may suggest a placental role in growth restrictive effects of prenatal maternal BET exposure through alterations in placental output of oPL, a key metabolic hormone of pregnancy.

UR - http://joe.endocrinology-journals.org/content/194/2/337.full.pdf+html

U2 - 10.1677/JOE-07-0123

DO - 10.1677/JOE-07-0123

M3 - Article

VL - 194

SP - 337

EP - 347

JO - Journal of Endocrinology

JF - Journal of Endocrinology

SN - 0022-0795

IS - 2

ER -